Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$147M |
| 2 |
Gilead Sciences
GILD
|
+$127M |
| 3 |
Intel
INTC
|
+$114M |
| 4 |
LO
LORILLARD INC COM STK
LO
|
+$113M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$243M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$148M |
| 3 |
UNS
UNS ENERGY CORP COM
UNS
|
+$123M |
| 4 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$118M |
| 5 |
CELG
Celgene Corp
CELG
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Technology | 13.5% |
| 3 | Energy | 10.11% |
| 4 | Financials | 9.6% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Cohen & Steers REIT and Preferred and Income Fund
RNP
$972M
| $2.12M | 0.01% |
121,291
-19,845
| -14% | -$360K |
|
|
SMA
1152
DELISTED
SYMMETRY MEDICAL INC
SMA
| $2.12M | 0.01% |
210,000
+154,900
| +281% | +$1.43M |
|
1153
Nuveen Preferred & Income Opportunities Fund
JPC
$2.81B
| $2.12M | 0.01% |
230,157
+49,853
| +28% | +$470K |
|
1154
Papa John's
PZZA
$793M
| $2.12M | 0.01% |
52,924
-1,300
| -2% | -$53.3K |
|
|
TCO
1155
DELISTED
Taubman Centers Inc.
TCO
| $2.11M | 0.01% |
28,930
+800
| +3% | +$60.2K |
|
|
ZLTQ
1156
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $2.11M | 0.01% |
93,231
+11,100
| +14% | +$220K |
|
1157
SITE Centers
SITC
$161M
| $2.1M | 0.01% |
97,633
-19,015
| -16% | -$432K |
|
1158
Stagwell
STGW
$2.17B
| $2.09M | 0.01% |
109,145
-161,100
| -60% | -$3.39M |
|
|
ONIT
1159
Onity Group
ONIT
$299M
| $2.09M | 0.01% |
5,329
+2,367
| +80% | +$1.07M |
|
1160
Avient
AVNT
$4.07B
| $2.09M | 0.01% |
58,786
-3,200
| -5% | -$126K |
|
|
PDT
1161
John Hancock Premium Dividend Fund
PDT
$617M
| $2.09M | 0.01% |
159,020
+3,232
| +2% | +$43K |
|
|
PTX
1162
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $2.08M | 0.01% |
27,040
+24,570
| +995% | +$1.93M |
|
|
ATW
1163
DELISTED
Atwood Oceanics
ATW
| $2.08M | 0.01% |
47,489
+4,200
| +10% | +$201K |
|
|
RCPT
1164
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $2.07M | 0.01% |
33,400
+18,600
| +126% | +$889K |
|
1165
Albany International
AIN
$1.66B
| $2.07M | 0.01% |
60,910
-41,000
| -40% | -$1.52M |
|
|
NPI
1166
DELISTED
NUVEEN PREMIUN INC MUN FUND
NPI
| $2.06M | 0.01% |
153,874
+21,478
| +16% | +$289K |
|
1167
G-III Apparel Group
GIII
$1.43B
| $2.06M | 0.01% |
49,752
-99,400
| -67% | -$4.07M |
|
1168
Enbridge
ENB
$109B
| $2.05M | 0.01% |
42,900
+28,700
| +202% | +$1.42M |
|
1169
XPO
XPO
$22.5B
| $2.03M | 0.01% |
156,034
-445,145
| -74% | -$4.86M |
|
1170
Chemed
CHE
$7.08B
| $2.03M | 0.01% |
19,751
-17,445
| -47% | -$1.77M |
|
1171
Exponent
EXPO
$3.37B
| $2.03M | 0.01% |
114,684
-13,200
| -10% | -$243K |
|
1172
LKQ Corp
LKQ
$6.51B
| $2.02M | 0.01% |
75,815
-52,200
| -41% | -$1.4M |
|
1173
Rogers Corp
ROG
$2.19B
| $2.01M | 0.01% |
36,720
+1,200
| +3% | +$72.5K |
|
1174
Wheaton Precious Metals
WPM
$72.8B
| $2.01M | 0.01% |
+100,800
| New | +$2.51M |
|
1175
Generac Holdings
GNRC
$12B
| $2M | 0.01% |
49,463
-197
| -0.4% | -$8.82K |
|
Similar funds
Cliff Asness's Q3 2014 Portfolio in Review
As of Q3 2014, Cliff Asness held 2,708 positions worth $36.4B, down 1.9% from $37.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Cliff Asness withdrew a net $2.61B in Q3 2014, closing 203 positions and reducing 1,062 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $243M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Energy.
Against the trend, Cliff Asness opened a new position in BALLY TECHNOLOGIES, INC. worth $80.5M.
- Cliff Asness's largest Q3 2014 buy was BALLY TECHNOLOGIES, INC.: 997,907 shares worth $80.5M.
- Cliff Asness added most to Shire pic in Q3 2014, an estimated $147M increase.
- Cliff Asness's biggest Q3 2014 reduction was Western Refining Inc, cutting an estimated $148M.
- Cliff Asness fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $243M.
- Cliff Asness's ten largest holdings make up 9.4% of its $36.4B portfolio in Q3 2014.
- Cliff Asness opened 200 new positions and closed 203 in Q3 2014.
- Cliff Asness's portfolio value fell 1.9% quarter-over-quarter to $36.4B.
Based on AQR Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.